Navigation Links
Govt to Shift its Focus From Curative to Preventive Mode of Healthcare

The government is shifting its focus from the curative mode of healthcare to the preventive one, Union Minister for Health and Family Welfare Anbumani Ramadoss said here Friday //.

'Children will be administered all viable vaccines, including those for Hepatitis B and Japanese Encephalitis. We are switching over to the preventive mode of medicare,' Ramadoss said after dedicating the Diarrhoeal Disease Research and Control Centre to the nation.

He said diarrhoeal diseases claim 0.7 million lives of children every year, thus emerging as the second largest killer in the country after respiratory diseases.

The new centre has come up in collaboration with the National Institute of Cholera and Enteric Diseases (NICED) and the Japan International Cooperation Agency (JICA). The Japanese government has extended a grant-in-aid of Rs.920 million for the its construction.

Ramadoss said the centre would soon launch an Integrated Disease Surveillance Project (IDSP) to bring a few diseases under the surveillance programme.

'Eleven parameters have been fixed for the purpose. Incidence of polio, HIV/AIDS, cholera, cardiovascular diseases and even road accidents will be brought under its purview,' he said.

'Within five hours of outbreak of any disease it will be notified and action will be taken immediately. All the districts of the country will be connected through satellite links for better surveillance. The total project cost is estimated at Rs.3.5 billion,' he said.

To supplement the IDSP, the National Institute of Communicable Diseases would be expanded and renamed as National Centre for Disease Control, the minister said.

The Indian Council of Medical Research (ICMR) will soon be made a separate department in the health ministry, which will be re-christened as ministry of health & family welfare and medical research, he said.

Talking on the sidelines of the programm
'"/>




Page: 1 2

Related medicine news :

1. Biocon To Shift Focus On Innovation To Accelerate Growth
2. Sex Ends as Seasons Shift and Kisspeptin Levels Plummet
3. Doctors Advise Shifting of Ailing Soren
4. Focus on DNA transcription
5. Focused Treatment For Childhood Cancer
6. Focussed treatment for Hodgkins disease
7. World Heart Day To Focus On Ideal Body Weight And Shape To Reduce Risk Of Heart Disease
8. Now Employers Focus On Employees Mental health
9. A New Focus For The Mechanism Of Nerve Growth
10. JRRD Focuses On Issues Such As Spinal Cord Injury and Prosthetics
11. UN research symposium To Focus on Open source and Open Medicine
Post Your Comments:
(Date:10/10/2008)...ewswire/ -- Do you think that the blind,can,t use ...nd the October,17 open house at the Virginia Rehab..., and see how instructors there empower the blind ...ng lives through non-visual,techniques taught at t...nue, is holding an open house to,celebrate the gra...
(Date:10/10/2008)...RNewswire/ -- NuView Life Sciences Inc.,(NuView) h...ces Inc.,(Trace), including operations of the line... in Denton, Texas. The Trace facility produces,Cop...llium-201 used in,molecular imaging and nuclear me...d that "We are confident that by improving operati...
(Date:10/10/2008)...artly to blame , , FRIDAY, Oct. 10 (Heal...s who have diabetes, being depressed was associate...dy. , Publishing in the October issue of the ...s from the University of Washington tracked 10,704...) who had diabetes and were enrolled in a disease ...
(Date:10/10/2008)... (NIH) scientists have identified a protein that p...od cells, T and B cells, enabling them to interact...ting immunity after an infection. Their finding m...netic defect that prevents them from making this p... a common virus that otherwise is rarely fatal (Ep...
Breaking Medicine News(10 mins):Health News:Virginia Rehabilitation Center for the Blind and Vision Impaired Celebrates Opening of New Student Dormitory 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:NIH scientists discover crucial control in long-lasting immunity 2Health News:NIH scientists discover crucial control in long-lasting immunity 3
...to a new study, patients with lung disease suffere...nhaled steroids. Researchers in Texas studied a gr...nary disease (COPD).// All received a high dose of...r a period of four months. After this time, they e...
...to a report, giving radiation to surgical treatmen...n the survival of patients. But the findings sugge...ery may help// improve the patient's quality of li...rrence at or near the original tumor site in the r...
...as invented and man learnt how to cook food. At fi...ety and a change from raw food, but today it domin...ste buds do appreciate raw food. Whether just to m...s or at home as a filler,no meal is complete witho...
...s in a study observed that human cytomegalovirus c...r. Although some people have a genetic predisposit...or no obvious reason.// Researchers at the Univers...link between viral infection and colon cancer. Fi...
Other Medicine News:Health News:Keep fit with salads 2Health News:Keep fit with salads 3
(Date:10/9/2008)...ted in November 2008, BOTHELL, Wash., Oct. 9 /PRN...DD ) announced today the completion of patient enr...tal trials to evaluate the safety and,efficacy of ...buprofen for,the over-the-counter (OTC) market. Th...this pivotal trial in November 2008. Ibuprofen is ...
(Date:10/8/2008)...wire-USNewswire/ -- The facts are,overwhelming. Ev...sub-Saharan Africa. More than 35,000,000 women, ch... died of AIDS. The Foundation for Hospices,in Sub-...their families,find compassion and relief from suf...nering initiative links African hospices and palli...
(Date:10/8/2008)...s Research That May Offer New Hope to,Heart Failur...nally, over 3,000 people are,waiting for a heart t...alf,of those will receive a transplant. Now, pione... paving the way for how to treat congestive heart,...ews Release, go to:, http://www.prnewswire.com/mnr...
(Date:10/8/2008)...e TAXUS(R) Element(TM) Platinum Chromium ... 8 /- Boston Scientific,Cor... completed enrollment in,the PERSEUS trial, design...S(R) Element(TM) paclitaxel-eluting coronary stent... 1,500 patients at 100 U.S. and,international cent...
Breaking Medicine Technology:SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 2In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 3In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 4Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 2Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 3Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 2Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 3Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 4Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 1Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 2Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 3Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 4Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 5Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 6Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 7Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 8Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 9Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 10Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 11Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 12Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 13Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 14Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 15Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 16Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 17Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 18Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 19Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 20Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 21Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 22Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 23Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 24Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 25Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 26Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 27Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 28Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 29Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 30Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 31Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 32Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 33Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 34Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 35Varian Inc Offers New Products for the Rapid Purification of Synthetic Oligonucleotides 5098 1Varian Inc Offers New Products for the Rapid Purification of Synthetic Oligonucleotides 5098 2Childrens gardens mushrooming 1053 1Childrens gardens mushrooming 1053 2Caesarean births pose higher risks for mother and baby 5096 1Caesarean births pose higher risks for mother and baby 5096 2
... July 3, 2007-- – The appearance of a,rash i... is,strongly associated with longer survival, acco...er, OSI Pharmaceuticals, Inc. This is,not the firs...al,advantage with EGFR inhibitors – a class ...tumumab and others designed to,block overproductio...
... July 3, 2007-- Ongoing therapeutic cancer vaccine...ring a,patient’s immune system to shrink tum...trials tend to live longer and respond,better to s...al,Cancer Research, a journal of the American Asso...ncer Institute researchers asks a,fundamental ques...
Other Medicine Technology:Skin Rash Actually Signifies Better Outcomes for Pancreatic and,Lung Cancer Patients 2Skin Rash Actually Signifies Better Outcomes for Pancreatic and,Lung Cancer Patients 3Skin Rash Actually Signifies Better Outcomes for Pancreatic and,Lung Cancer Patients 4From Clinical Cancer Research: Rethinking Therapeutic Cancer,Vaccine Trials 2From Clinical Cancer Research: Rethinking Therapeutic Cancer,Vaccine Trials 3
The very popular and competitively priced SportNeb features a 35 PSI, die-cast aluminum compressor. Design enhancements include a neb kit holder, built-in cord storage and optional black carry bag. T
...act Compressor provides effective therapy at an af...r therapy at home or on the go and features ease o...eration you have come to count on from DeVilbiss.,... solution for those patients seeking a quality, ef...
...unit with a unique docking port to hold a Salter N...integrated uni-position for quiet, powerful operat...mbinations with Salter Nebulizers, Masks and Mouth...le. , ,The Salter AIRE Plus® Compressor (115...
Whether you require high flow rates for critical situations or lower rates for others, this insufflator handles both situations equally well, regulated by the preselected pressure.
Medicine Products: